Thanks to the outstanding efforts of its employees and affiliated doctors, the hospital group was able to further optimise its medical services, allowing more patients to access both outpatient (+8%) and inpatient (+4.2%) care.
Revenue in 2025 increased to CHF 503 million (+5%). EBITDAR amounted to CHF 41.3 million in 2025, corresponding to a margin of 8.3% (previous year 6.6%). The proportion of semi-private and private insured patients remained stable at 21.2%.
Operating expenses rose to around CHF 491 million. Adjusted for depreciation, the increase is 3.1%. The shortage of skilled workers is still noticeable in the Lindenhofgruppe. After the costs for temporary staff were reduced in the previous year, an increase was noted again.
The Lindenhofgruppe has decided to transfer the inpatient services from the Engeried location to Lindenhof Hospital by the end of 2025. In this context, further investments have been made in the infrastructure at the Lindenhof location. The challenges in the market remain high. In addition to the introduction of TARDOC/ambulatory flat rates, the Lindenhofgruppe introduced a new Enterprise Resource Planning System (ERP) at the beginning of 2026. Despite good developments in the past two years, profitability is still insufficient to secure future investment needs. Pressure on tariffs continues.
The Lindenhofgruppe lets its employees share in the improved outcome and increased its payroll by 1% again in 2026 while giving everyone a small bonus. Moreover, it offers numerous flexible working models with many benefits.
Thanks to its highly competent and motivated staff and affiliated doctors, the Lindenhofgruppe will continue to make an important contribution to healthcare in the canton of Bern in the future. This with a focus on particularly high treatment quality and placing the well-being of people at the centre of its services.
Press Contact:
Email: medienstelle@lindenhofgruppe.ch
Phone: +41 31 300 75 05